Placebo Effect and Efficacy of Nebivolol in Patients with Hypertension not Controlled with Lisinopril or Losartan: A Phase IV, Randomized, Placebo-Controlled Trial

[1] Chobanian AV(2003)Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure Hypertension 42 1206-1252

[2] Bakris GL(2010)Combination therapy in hypertension J Am Soc Hypertens 4 42-50

[3] Black HR(2009)Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials Am J Med 122 290-300

[4] Cushman WC(2009)Nebivolol: the somewhat-different beta-adrenergic receptor blocker J Am Coll Cardiol 54 1491-1499

[5] Green LA(2011)Efficacy and tolerability of nebivolol in stage I–II hypertension: a pooled analysis of data from three randomized, placebo-controlled monotherapy trials Clin Ther 33 1150-1161

[6] Izzo JL(2010)Adding nebivolol to ongoing antihypertensive therapy improves blood pressure and response rates in patients with uncontrolled stage I-II hypertension J Hum Hypertens 24 64-73

[7] Gradman AH(2012)Blood pressure effects of combined beta blocker and angiotensin converting enzyme inhibitor therapy compared with the individual agents: a placebo-controlled study with nebivolol and lisinopril J Clin Hypertens (Greenwich) 14 588-592

[8] Basile JN(1994)Placebo-controlled comparison of the effects of nebivolol and low-dose hydrochlorothiazide as monotherapies and in combination on blood pressure and lipid profile in hypertensive patients J Hum Hypertens 8 283-288

[9] Carter BL(1994)Treatment of ambulatory hypertensives with nebivolol or hydrochlorothiazide alone and in combination. A randomized, double-blind, placebo-controlled, factorial-design trial Am J Hypertens 7 137-145

[10] Bakris GL(2005)International variation in prescribing antihypertensive drugs: its extent and possible explanations BMC Health Serv Res 5 21-221

[1] Chobanian AV(2003)Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure Hypertension 42 1206-1252

[2] Bakris GL(2010)Combination therapy in hypertension J Am Soc Hypertens 4 42-50

[3] Black HR(2009)Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials Am J Med 122 290-300

[4] Cushman WC(2009)Nebivolol: the somewhat-different beta-adrenergic receptor blocker J Am Coll Cardiol 54 1491-1499

[5] Green LA(2011)Efficacy and tolerability of nebivolol in stage I–II hypertension: a pooled analysis of data from three randomized, placebo-controlled monotherapy trials Clin Ther 33 1150-1161

[6] Izzo JL(2010)Adding nebivolol to ongoing antihypertensive therapy improves blood pressure and response rates in patients with uncontrolled stage I-II hypertension J Hum Hypertens 24 64-73

[7] Gradman AH(2012)Blood pressure effects of combined beta blocker and angiotensin converting enzyme inhibitor therapy compared with the individual agents: a placebo-controlled study with nebivolol and lisinopril J Clin Hypertens (Greenwich) 14 588-592

[8] Basile JN(1994)Placebo-controlled comparison of the effects of nebivolol and low-dose hydrochlorothiazide as monotherapies and in combination on blood pressure and lipid profile in hypertensive patients J Hum Hypertens 8 283-288

[9] Carter BL(1994)Treatment of ambulatory hypertensives with nebivolol or hydrochlorothiazide alone and in combination. A randomized, double-blind, placebo-controlled, factorial-design trial Am J Hypertens 7 137-145

[10] Bakris GL(2005)International variation in prescribing antihypertensive drugs: its extent and possible explanations BMC Health Serv Res 5 21-221